Comparison of Tumor Enucleation and Standard Partial Nephrectomy According to Trifecta Outcomes: A Multicenter Study by the Turkish Academy of Urology, Uro-Oncology Working Group.


Journal

Journal of investigative surgery : the official journal of the Academy of Surgical Research
ISSN: 1521-0553
Titre abrégé: J Invest Surg
Pays: United States
ID NLM: 8809255

Informations de publication

Date de publication:
May 2022
Historique:
pubmed: 17 12 2021
medline: 28 4 2022
entrez: 16 12 2021
Statut: ppublish

Résumé

We aimed to evaluate the impact of the resection technique (tumor enucleation (TE) or standard partial nephrectomy (SPN)) on trifecta outcomes in patients having undergone partial nephrectomy (PN). We retrospectively analyzed the clinical and pathologic parameters in patients with localized renal cell carcinoma (pT1-2N0M0) who had undergone PN between January 2001-December 2018 at one of 15 different tertiary referral centers. Multivariable logistic regression analysis was applied to investigate independent predictors of trifecta failure, decreased postoperative renal functions (decreased estimated glomerular filtration rate (eGFR) > 10%), perioperative complications (Clavien-Dindo > 1), and positive surgical margins. A total of 1070 patients with a mean age 56.11 ± 11.88 years were included in our study. PN was performed with TE in 848 (79.25%) and SPN in 222 (20.75%) patients. Trifecta failure rate was 56.2% for TE and 64.4% for SPN ( TE is associated with less trifecta failure than SPN. This result is mainly due to better preservation of renal function with TE.

Identifiants

pubmed: 34913804
doi: 10.1080/08941939.2021.2015490
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1112-1118

Auteurs

Meftun Culpan (M)

Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

Gokhan Atis (G)

Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

Oner Sanli (O)

Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Yasar Bozkurt (Y)

Department of Urology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.

Ali Fuat Atmaca (AF)

Faculty of Medicine, Department of Urology, Ankara Yildirim Beyazit University, Ankara, Turkey.

Bülent Semerci (B)

Faculty of Medicine, Department of Urology, Ege University, Izmir, Turkey.

Cemil Kutsal (C)

Department of Urology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.

Abdullah Erdem Canda (AE)

School of Medicine, Department of Urology, Koc University, Istanbul, Turkey.

Fatih Akbulut (F)

Department of Urology, University of Health Sciences, Haseki Training and Research Hospital, Istanbul, Turkey.

Volkan Tugcu (V)

Department of Urology, University of Health Sciences, Bakirkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Ugur Boylu (U)

Department of Urology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey.

Sakip Erturhan (S)

School of Medicine, Department of Urology, Gaziantep University, Gaziantep, Turkey.

Orhan Koca (O)

Department of Urology, University of Health Sciences, Haydarpasa Training and Research Hospital, Istanbul, Turkey.

Ferhat Ateş (F)

Department of Urology, University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.

Fikret Halis (F)

Department of Urology, Sakarya University Training and Research Hospital, Sakarya, Turkey.

Sedat Soyupek (S)

School of Medicine, Department of Urology, Suleyman Demirel University, Isparta, Turkey.

Burak Turna (B)

Faculty of Medicine, Department of Urology, Ege University, Izmir, Turkey.

Sedat Cakmak (S)

Department of Urology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.

Selcuk Sahin (S)

Department of Urology, University of Health Sciences, Bakirkoy Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Selcuk Erdem (S)

Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Asif Yildirim (A)

Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH